50 participants
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-14
- Start Date:
- 2026-09-30
- Completion:
- 2031-12-31
Conditions
- HER2 + Breast Cancer
- Advanced Breast Cancer
Interventions
- DRUG
No Results Yet